PTPRC and cancer: Although CD301 has been reported to bind CD45 (RA, RB, and RC) on normal T and B cells,42 we find that CD301 does not significantly bind to resting B cells or resting/activated T cells at concentrations that readily bind to Tn+ cancer cells (Figures S2C and S2E).